ctrl K

AI Score

Unlock

Unicycive Therapeutics In... (UNCY)

AI Score

Unlock

0.54

-0.02 (-4.34%)

At close: Feb 28, 2025, 3:59 PM

0.55

2.67%

After-hours: Feb 28, 2025, 04:00 PM EST

Unicycive Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	675K	951K	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	7K	1K	n/a	n/a	n/a
Gross Profit	675K	944K	-1K	n/a	n/a	n/a
Operating Income	-20.77M	-18.05M	-8.98M	-2.02M	-1.96M	-952K
Interest Income	615K	6K	628K	244K	139K	168K
Pretax Income	-30.54M	-18.06M	-10.02M	-2.26M	-2.17M	-1.12M
Net Income	-30.54M	-18.06M	-10.63M	-2.51M	-2.3M	-1.12M
Selling & General & Admin	8.55M	6.57M	2.9M	1M	1.17M	608K
Research & Development	12.9M	12.44M	6.08M	1.01M	795K	344K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	21.45M	19M	8.98M	2.02M	1.96M	952K
Interest Expense	82K	6K	628K	244K	139K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	21.45M	19M	8.98M	2.02M	1.96M	952K
Income Tax	n/a	6K	615K	244K	139K	-952K
Shares Outstanding (Basic)	24.54M	15.06M	15M	15.25M	8.43M	7.94M
Shares Outstanding (Diluted)	24.54M	15.06M	15M	15.25M	8.47M	7.94M
EPS (Basic)	-1.28	-1.2	-0.71	-0.16	-0.27	-0.14
EPS (Diluted)	-1.28	-1.2	-0.71	-0.16	-0.27	-0.14
EBITDA	-30.18M	-18.05M	-8.98M	n/a	-63K	n/a
Depreciation & Amortization	284K	7K	1K	2.02M	1.96M	952K